EuBiotics Typhoid Vaccine EuTYPH-C Secures WHO Prequalification, Unlocking Global Procurement Access
Korean vaccine maker EuBiotics wins WHO Prequalification for typhoid conjugate vaccine EuTYPH-C, opening access to UNICEF and international public health procurement markets.
Key points
- EuBiotics typhoid vaccine EuTYPH-C secures WHO Prequalification opening UNICEF market access
- Korean biotech achieves global vaccine quality standard enabling international procurement bids
- UNICEF tender wins will be the key test of whether WHO PQ converts to revenue
What’s your take on this? Join the discussion below.
Read the full analysis on market.news
🇰🇷 South Korea Stocks Regulatory biotech pharma healthcare asia